+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compounded bioidentical menopausal hormone therapy



Compounded bioidentical menopausal hormone therapy



Fertility and Sterility 98(2): 308-312



Although improvement in long-term health is no longer an indication for menopausal hormone therapy, evidence supporting fewer adverse events in younger women, combined with its high overall effectiveness, has reinforced its usefulness for short-term treatment of menopausal symptoms. Menopausal therapy has been provided not only by commercially available products but also by compounding, or creation of an individualized preparation in response to a health care provider's prescription to create a medication tailored to the specialized needs of an individual patient. The Women's Health Initiative findings, coupled with an increase in the direct-to-consumer marketing and media promotion of compounded bioidentical hormonal preparations as safe and effective alternatives to conventional menopausal hormone therapy, have led to a recent increase in the popularity of compounded bioidentical hormones as well as an increase in questions about the use of these preparations. Not only is evidence lacking to support superiority claims of compounded bioidentical hormones over conventional menopausal hormone therapy, but these claims also pose the additional risks of variable purity and potency and lack efficacy and safety data. The Committee on Gynecologic Practice of the American College of Obstetricians and Gynecologists and the Practice Committee of the American Society for Reproductive Medicine provide an overview of the major issues of concern surrounding compounded bioidentical menopausal hormone therapy and provide recommendations for patient counseling.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269279

Download citation: RISBibTeXText

PMID: 22831824

DOI: 10.1016/j.fertnstert.2012.06.002


Related references

Committee opinion No. 532: compounded bioidentical menopausal hormone therapy. Obstetrics and Gynecology 120(2 Pt 1): 411-415, 2014

Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making. Bmc Women's Health 17(1): 97, 2018

Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2. International Journal of Pharmaceutical Compounding 20(6): 447-454, 2017

What are bioidentical hormones? Natural. Bioidentical. Compounded. Confusion about these terms is only adding to the confusion over hormone therapy. Harvard Women's Health Watch 13(12): 1-3, 2006

What are the concerns about custom-compounded "bioidentical" hormone therapy?. Menopause 21(12): 1298-1300, 2015

Think twice before prescribing custom-compounded bioidentical hormone therapy. Journal of Women's Health 23(8): 631-633, 2014

Efficacy and tolerability of compounded bioidentical hormone replacement therapy. International Journal of Pharmaceutical Compounding 8(4): 313-319, 2004

Compounded bioidentical hormone therapy: time for a reality check?. Menopause 22(9): 919-920, 2016

Misconception and concerns about bioidentical hormones used for custom-compounded hormone therapy. Journal of Clinical Endocrinology and Metabolism 97(3): 756-759, 2012

Risks and effectiveness of compounded bioidentical hormone therapy: a case series. Journal of Women's Health 23(8): 642-648, 2014

Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women. Menopause 22(9): 926-936, 2016

Effectiveness of compounded bioidentical hormone replacement therapy: an observational cohort study. Bmc Women's Health 11: 27, 2011

Compounded Bioidentical Hormone Therapy: Does the Regulatory Double Standard Harm Women?. JAMA Internal Medicine 177(12): 1719-1720, 2017

Compounded or confused? Bioidentical hormones and menopausal health. Menopause International 17(1): 16-18, 2011

Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use. Climacteric 20(3): 205-211, 2018